reports
- Jonathan Moreland
Texas Capital Bancshares, Inc. Announces Date for Full Year and Q4 202...
Texas Capital Bancshares, Inc. Announces Date for Full Year and Q4 2025 Operating Results DALLAS, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital Bank, today announced that it expects to issue financial results for the full year and fourth quarter of 2025 before market on Thursday, January 22, 2026. Executive management will host a conference call and webcast to discuss full year and fourth quarter 2025 operating results on Thursday, January 22, 2026, at 9:00 a.m. EDT. Participants may pre-register for the call by visit...
- Jonathan Moreland
- Jonathan Moreland
NWBI NORTHWEST BANCSHARES INC.
MMLP MARTIN MIDSTREAM PARTNERS L.P.
DIN DINE BRANDS GLOBAL INC.
CRM SALESFORCE.COM INC.
CBRL CRACKER BARREL OLD COUNTRY STORE INC.
TZOO TRAVELZOO
NHF NEXPOINT CREDIT STRATEGIES FUN
DMAC DIAMEDICA THERAPEUTICS INC.
ZIP ZIPRECRUITER
NRDY INC.
LIN NERDY INC.
MXF LINDE PUBLIC LIMITED COMPANY
MDRR THE MEXICO FUND
GF INC.
CBIO MEDALIST DIVERSIFIED REIT INC.
SINT THE NEW GERMANY FUND
GMRE INC.
SEVN CRESCENT BIOPHARMA INC.
SINTX TECHNOLOGIES INC.
GLOBAL MEDICAL REIT INC.
SEVEN HILLS REALTY TRUST
Inhibikase Therapeutics Announces Pricing of $100 Million Public Offer...
Inhibikase Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded Warrants WILMINGTON, Del., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (NASDAQ: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing therapeutics to modify the course of pulmonary arterial hypertension (“PAH”), today announced the pricing of its underwritten public offering of 46,091,739 shares of common stock and pre-funded warrants to purchase 22,873,779 shares of common stock. The shares of common stock are being sold at an offeri...
Inhibikase Therapeutics Announces Proposed Public Offering of Common S...
Inhibikase Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants BOSTON and ATLANTA, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (NASDAQ: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing therapeutics to modify the course of pulmonary arterial hypertension (“PAH”), today announced that it has commenced an underwritten public offering of shares of its common stock and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase shares of its common stock. In addition, I...
Inhibikase Therapeutics Advancing IKT-001 to Global Phase 3 Study in P...
Inhibikase Therapeutics Advancing IKT-001 to Global Phase 3 Study in Pulmonary Arterial Hypertension Phase 3 Study initiating in First Quarter of 2026 Single Pivotal Study Accelerates Potential FDA Approval Timeline by Approximately 3 Years BOSTON and ATLANTA, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases namely, Pulmonary Arterial Hypertension (“PAH”), today announced that it expects to advance IKT-001 to a global...
Texas Capital Announces the Liquidation of the Texas Small Cap Equity ...
Texas Capital Announces the Liquidation of the Texas Small Cap Equity Index ETF DALLAS, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The Board of Trustees of the Texas Capital Funds Trust (the “Board”) has authorized an orderly liquidation of the Texas Capital Texas Small Cap Equity Index ETF (NASDAQ: TXSS) (the “Fund”). After careful consideration of the Fund’s size, asset composition and growth trajectory, the Board determined that it is advisable and in the best interest of the Fund and its shareholders to liquidate the Fund. As constructed, TXSS shared some of the portfolio constituents and othe...
Inhibikase Therapeutics Announces Third Quarter 2025 Financial Results...
Inhibikase Therapeutics Announces Third Quarter 2025 Financial Results and Highlights Recent Activity BOSTON and ATLANTA, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases namely, Pulmonary Arterial Hypertension (“PAH”), today reported financial results for the quarter ended September 30, 2025 and highlighted recent developments. “During our third quarter of 2025, we continued to position the Company to advance IKT-001 t...
- Jonathan Moreland
MTDR MATADOR RESOURCES COMPANY
MNRO MONRO INC
GBCI GLACIER BANCORP INC.
EIG EMPLOYERS HOLDINGS INC.
CNS COHEN & STEERS INC.
AROW ARROW FINANCIAL CORP.
GAM GENERAL AMERICAN INVESTORS CO. INC.
HWKN HAWKINS INC.
BX THE BLACKSTONE GROUP L.P.
OSPN ONESPAN
FUSB FIRST US BANCSHARES INC
SPT SPROUT SOCIAL
AWRE INC.
ZIP AWARE INC.
EXFY ZIPRECRUITER
OKE INC.
LAW EXPENSIFY INC
RMI ONEOK
INC.
CS DISCO INC
RIVERNORTH OPPOR MUN INC FD INC
- Jonathan Moreland
TCBI TEXAS CAPITAL BANCSHARES INC.
EVEREST RE GROUP LTD.
OPK OPKO HEALTH INC.
MOFG MIDWESTONE FINANCIAL GROUP
FMNB FARMERS NATIONAL BANC CORP.
FFIN FIRST FINANCIAL BANKSHARES INC
FCN FTI CONSULTING INC.
CRMD CORMEDIX INC.
CNS COHEN & STEERS INC.
CINF CINCINNATI FINANCIAL CORPORATION
BAH BOOZ ALLEN HAMILTON HOLDING CORPORATION CLASS A
ANGO ANGIODYNAMICS INC.
GAM GENERAL AMERICAN INVESTORS CO. INC.
QRHC QUEST RESOURCE HOLDING
QTA QUATERRA RESOURCES INC.
ATRO ASTRONICS CORPORATION
NSC NORFOLK SOUTHERN CORPORATION
INBK FIRST INTERNET BANCORP
GCBC GREENE COUNTY BANCORP INC.
UTG REAVES UTILITY INCOME FUND
ITGR INTEGER HOLDINGS CORPORATION
WDFC WD-40 COMPANY
BX THE BLACKSTONE GROUP L.P.
XFLT XAI OCTAGON FLOATING RATE ALTERNATIVE INCOME TERM TRUST
WGO WINNEBAGO INDUSTRIES INC.
NWFL NORWOOD FINANCIAL CORP.
OBNK ORIGIN BANCORP
CHMG CHEMUNG FINANCIAL CORP.
AVTR AVANTOR
RYES INC.
VRDN PATRIOT MINEFINDERS INC.
SMMT VIRIDIAN THERAPEUTICS INC
INTA SUMMIT THERAPEUTICS INC
NVCT INTAPP INC
EBC NUVECTIS PHARMA INC
NMRA EASTERN BANKSHARES INC
EP NEUMORA THERAPEUTICS INC
CLS EMPIRE PETROLEUM CORP
GF CELESTICA INC.
ECF THE NEW GERMANY FUND
NUGN INC.
XFOR ELLSWORTH FUND LTD
STBA LIVENTO GROUP
KITT INC.
X4 PHARMACEUTICALS INC.
S&T BANCORP
INC.
NAUTICUS ROBOTICS HOLDINGS INC.
- Jonathan Moreland
TCBI TEXAS CAPITAL BANCSHARES INC.
EVEREST RE GROUP LTD.
OPK OPKO HEALTH INC.
MOFG MIDWESTONE FINANCIAL GROUP
FMNB FARMERS NATIONAL BANC CORP.
FFIN FIRST FINANCIAL BANKSHARES INC
FCN FTI CONSULTING INC.
CRMD CORMEDIX INC.
CNS COHEN & STEERS INC.
CINF CINCINNATI FINANCIAL CORPORATION
BAH BOOZ ALLEN HAMILTON HOLDING CORPORATION CLASS A
ANGO ANGIODYNAMICS INC.
GAM GENERAL AMERICAN INVESTORS CO. INC.
QRHC QUEST RESOURCE HOLDING
QTA QUATERRA RESOURCES INC.
ATRO ASTRONICS CORPORATION
NSC NORFOLK SOUTHERN CORPORATION
INBK FIRST INTERNET BANCORP
GCBC GREENE COUNTY BANCORP INC.
UTG REAVES UTILITY INCOME FUND
ITGR INTEGER HOLDINGS CORPORATION
WDFC WD-40 COMPANY
BX THE BLACKSTONE GROUP L.P.
XFLT XAI OCTAGON FLOATING RATE ALTERNATIVE INCOME TERM TRUST
WGO WINNEBAGO INDUSTRIES INC.
NWFL NORWOOD FINANCIAL CORP.
OBNK ORIGIN BANCORP
CHMG CHEMUNG FINANCIAL CORP.
AVTR AVANTOR
RYES INC.
VRDN PATRIOT MINEFINDERS INC.
SMMT VIRIDIAN THERAPEUTICS INC
INTA SUMMIT THERAPEUTICS INC
NVCT INTAPP INC
EBC NUVECTIS PHARMA INC
NMRA EASTERN BANKSHARES INC
EP NEUMORA THERAPEUTICS INC
CLS EMPIRE PETROLEUM CORP
GF CELESTICA INC.
ECF THE NEW GERMANY FUND
NUGN INC.
XFOR ELLSWORTH FUND LTD
STBA LIVENTO GROUP
KITT INC.
X4 PHARMACEUTICALS INC.
S&T BANCORP
INC.
NAUTICUS ROBOTICS HOLDINGS INC.
- Jonathan Moreland
TCBI TEXAS CAPITAL BANCSHARES INC.
RHI ROBERT HALF INTERNATIONAL INC.
EVEREST RE GROUP LTD.
FMNB FARMERS NATIONAL BANC CORP.
CINF CINCINNATI FINANCIAL CORPORATION
BAH BOOZ ALLEN HAMILTON HOLDING CORPORATION CLASS A
ASA ASA
GAM GENERAL AMERICAN INVESTORS CO. INC.
INBK FIRST INTERNET BANCORP
GCBC GREENE COUNTY BANCORP INC.
ITGR INTEGER HOLDINGS CORPORATION
WDFC WD-40 COMPANY
CHMG CHEMUNG FINANCIAL CORP.
CGEM CULLINAN ONCOLOGY INC
CLS CELESTICA INC.
GF THE NEW GERMANY FUND
ECF INC.
STBA ELLSWORTH FUND LTD
S&T BANCORP
INC.
- Jonathan Moreland
ASA ASA
NSC NORFOLK SOUTHERN CORPORATION
RVP RETRACTABLE TECHNOLOGIES INC.
RMCF ROCKY MOUNTAIN CHOCOLATE FACTORY INC.
NWFL NORWOOD FINANCIAL CORP.
BWB BRIDGEWATER BANCSHARES
RYES PATRIOT MINEFINDERS INC.
BHRB BURKE & HERBERT BANK & TR/VA
EBC EASTERN BANKSHARES INC
VANI VIVANI MEDICAL INC
GF THE NEW GERMANY FUND
INC.
Texas Capital Bancshares, Inc. Announces Quarterly Dividend for Prefer...
Texas Capital Bancshares, Inc. Announces Quarterly Dividend for Preferred Stock DALLAS, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital Bank, and its board of directors declared a cash dividend of $14.375 per share of the 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series B (the “Series B Preferred Stock”), equivalent to $0.359375 per depositary share, each representing a 1/40th interest in a share of the Series B Preferred Stock. The depositary shares are traded on the NASDAQ under the symbol “TCBIO.” The...
Texas Capital Bancshares, Inc. Announces Third Quarter 2025 Results
Texas Capital Bancshares, Inc. Announces Third Quarter 2025 Results Third quarter 2025 ROAA of 1.30% Record-level net income of $105.2 million, record-level net income available to common stockholders of $100.9 million and record-level diluted earnings per share of $2.18 for the third quarter of 2025 Record-level Book Value and record-level Tangible Book Value(2) per share of $73.05 and $73.02, respectively Growth in capital ratios continues, achieving 12.1% CET1 and 16.1% Total Capital DALLAS, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent...
- Jonathan Moreland
Texas Capital Bancshares, Inc. Announces Date for Q3 2025 Operating Re...
Texas Capital Bancshares, Inc. Announces Date for Q3 2025 Operating Results DALLAS, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital Bank, today announced that it expects to issue financial results for the third quarter of 2025 after market on Wednesday, October 22, 2025. Executive management will host a conference call and webcast to discuss third quarter 2025 operating results on Wednesday, October 22, 2025, at 5:00 p.m. EDT. Participants may pre-register for the call by visiting and will receive a unique PIN number t...
- Jonathan Moreland
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.